What happened to ... - The Observer 26th August 2007

On 3 June, 2007, The Observer reported that sick children who had taken part in a revolutionary drug trial faced the prospect of having the treatment taken away from them because of NHS cost-cutting. The children - who suffered from the rare blood disorder sickle cell anaemia - had seen their lives transformed by the drug, Exjade. Instead of having a needle inserted in their stomach for eight to 12 hours a night as part of their treatment they simply took two tablets each day.

Link to Article